Production and Expression of Gro-α and RANTES by Peripheral Blood Mononuclear Cells Isolated from Patients with Kawasaki Disease and Measles

Journal of Korean Medical Science

Volumn 18, Issue 3, 2003, Pages 381-386

  Kim, Hee Sun ^a   Kim, Won Duk ^b   Lee, Young Hwan ^c  

^a Yeungnam University College of Medicine   (South Korea)

^b Dongguk University College of Medicine   (South Korea)

^c Young Nam University Hospital   (South Korea)

Author keywords

Chemokines; Measles; Mucocutaneous Lymph Node Syndrome; RANTES; Vasculitis

Indexed keywords

CHEMOKINE; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR ALPHA; PROTEIN SUBUNIT; RANTES; UNCLASSIFIED DRUG;

ARTICLE; CELL ISOLATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INFANT; MALE; MEASLES; MONONUCLEAR CELL; MUCOCUTANEOUS LYMPH NODE SYNDROME; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0347694780     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2003.18.3.381     Document Type: Article

References (40)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Jpn J Allerg 1967; 16: 178-222.
2. Leung DYM. Immunologic aspects of Kawasaki syndrome. J Rheumatol 1990; 17(Suppl 24): 15-8.
3. Leung DYM, Geha RS, Newburger JW, Burns JC, Fiers W, Lapierre LA, Pober JS. Two monokines, interleukin-1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med 1986; 164: 1958-72.
4. Leung DYM, Cotran RS, Kurt-Jones E, Burns JC, Newburger JW, Pober JS. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet 1989; 2: 1298-302.
5. Wong M, Silverman ED, Fish EN. Evidence for RANTES, monocyte chemotactic protein-1, and macrophage inflammatory protein-1 β, expression in Kawasaki disease. J Rheumatol 1997; 24: 1179-85.
6. Schall TJ. The chemokines. In: The Chemokine Handbook, 2nd ed. New York: Academic Press, 1994; 419-60.
7. Lin CY, Lin CC, Hwang B, Chiang BN. The changes of interleukin-2, tumor necrosis factor and gamma interferon production among patients with Kawasaki disease. Eur J Pediatr 1991; 150: 179-82.
8. Lang BA, Silverman ED, Laxer RM, Lau AS. Spontaneous tumor necrosis factor production in Kawasaki disease. J Pediatr 1989; 115: 939-43.
9. Matsubara T, Furukawa S, Yabuta K. Serum levels of tumor necrosis factor, interleukin-2 receptor, and interferon-gamma in Kawasaki disease. Clin Immunol Immunopathol 1990; 56: 29-36.
10. Maury CPJ, Salo E, Pelkonen P. Circulating interleukin-1 β, in patients with Kawasaki disease. N Engl J Med 1988; 319: 1670-1.
11. Eberhard BA, Andersson U, Laxer RM, Rose V, Silverman ED. Evaluation of the cytokine response in Kawasaki disease. Pediatr Infect Dis J 1995; 14: 199-203.
12. Lang BA, Silverman ED, Laxer RM, Rose V, Nelson DL, Rubin LA. Serum soluble interleukin-2 receptor levels in Kawasaki disease. J Pediatr 1990; 116: 592-6.
13. Rowley AH, Shulman ST, Preble OT, Poiesz BJ, Ehrlich GD, Sullivan JR. Serum interferon concentrations and retroviral serology in Kawasaki syndrome. Pediatr Infect Dis J 1988; 7: 663-6.
14. Furukawa S, Matsubara T, Jujoh K, Yone K, Sugawara T, Sasai K, Kato H, Yabuta K. Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol 1988; 48: 247-51.
15. Ueno Y, Takano N, Kanegane H, Yokoi T, Yachie A, Miyawaki T, Taniguchi N. The acute phase nature of interleukin-6: studies in Kawasaki disease and other febrile illnesses. Clin Exp Immunol 1989; 76: 337-42.
16. Lin CY, Lin CC, Hwang B, Chiang BN. Cytokines predict coronary aneurysm formation in Kawasaki disease patients. Eur J Pediatr 1993; 152: 309-12.
17. Research Committee on Kawasaki disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Tokyo, Japan: Ministry of Health and Welfare; 1984.
18. Kim HS, Lee YS, Kim SK, Cha HS. Effect of C. albicans on IL-6 gene expression of human peripheral blood lymphocytes. Korean J Immunol 1997; 19: 263-76.
19. Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics 1978; 61: 100-7.
20. Hirose S, Hamashima Y. Morphological observations on the vasculitis in the mucocutaneous lymph node syndrome: A skin biopsy study of 27 patients. Eur J Pediatr 1978; 129: 17-27.
21. Leung DYM. The potential role of cytokine-mediated vascular endothelial activation in the pathogenesis of Kawasaki disease. Acta Paediatr Jpn 1991; 33: 739-44.
22. Richmond A, Shattuck RL. Melanoma growth stimulatory activity: physiology, biology, structure/function, and role in disease. In: Horuk R, ed. Chemoattractant Ligands and their Receptors, Boca Raton, CRC Press, 1996; 87-124.
23. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 1994; 55: 97-179.
24. Kelner GS, Kennedy J, Bacon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, Copeland NG, Bazan JF, Moore KW, Schall TJ, Zlotnik A. Lymphotactin: a cytokine that represents a new class of chemokine. Science 1994; 266: 1395-9.
25. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ. A new class of membrane-bound chemokine with a CX(3)C motif. Nature 1997; 385: 640-4.
26. Schroder JM, Gregory H, Young J, Christophers E. Neutrophil-activating proteins in psoriasis. J Invest Dermatol 1992; 98: 241-7.
27. Tettelbach W, Nanney L, Ellis D, King L, Richmond A. Localization of MGSA/GRO protein in cutaneous lesions. J Cutan Pathol 1993; 20: 259-66.
28. Koch AE, Kunkel SL, Shah MR, Hosaka S, Halloran MM, Haines GK, Burdick MD, Pope RM, Strieter RM. Growth-related gene product alpha A chemotactic cytokine for neutrophils in rheumatoid arthritis. J Immunol 1995; 155: 3660-6.
29. Isaacs KL, Sartor RB, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992; 103: 1587-95.
30. Strieter RM, Polverini PJ, Arenberg DA, Walz A, Opdenakker G, Van Damme J, Kunkel SL. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leukoc Biol 1995; 57: 752-62.
31. Tanaka F, Dannenberg AM Jr, Higuchi K, Nakamura M, Pula PJ, Hugli TE, Discipio RG, Kreutzer DL. Chemotactic factors released in culture by intact developing and healing skin lesions produced in rabbits by the irritant sulfur mustard. Inflammation 1997; 21: 251-67.
32. Tsuruta J, Sugisaki K, Dannenberg AM Jr, Yoshimura T, Abe Y, Mounts P. The cytokines NAP-1 (IL-8), MCP-I, IL-1 beta and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard. Inflammation 1996; 20: 293-318.
33. Asano T, Ogawa S. Expression of IL-8 in Kawasaki disease. Clin Exp Immunol 2000; 122: 514-9.
34. Noe KH, Cenciarelli C, Moyer SA, Rota PA, Shin ML. Requirements for measles virus induction of RANTES chemokine in human astrocytoma-derived U373 cells. J Virol 1999; 73: 3117-24.
35. Plater-Zyberk C, Vencovsky J, Power CA. Chemokines in rheumatoid arthritis: Chemokines in disease. In: Hebert CA, ed. Biology and Clinical Research. Totowa, NJ: Humana Press Inc, 1999; 151-8.
36. Lukas NW. The role of chemokines in allergic airway inflammation: Chemokines in disease. In: Hebert CA, ed. Biology and Clinical Research. Totowa, NJ: Humana Press Inc, 1999; 111-21.
37. Hesselgesser J, Horuk R. Chemokines and chemokine receptors in the brain: Chemokines in disease. In: Hebert CA, ed. Biology and Clinical Research. Totowa, NJ: Humana Press Inc, 1999; 295-312.
38. Terai M, Jibiki T, Harada A, Terashima Y, Yasukawa K, Tateno S, Hamada H, Oana S, Niimi H, Matsushima K. Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment. J Leukoc Biol 1999; 65: 566-72.
39. Asano T, Ogawa S. Expression of monocyte chemoattractant protein-1 in Kawasaki disease: the anti-inflammatory effect of gamma globulin therapy. Scand J Immunol 2000; 51: 98-103.
40. Suzuki H, Noda E, Miyawaki M, Takeuchi T, Uemura S, Koike M. Serum levels of neutrophil activation cytokines in Kawasaki disease. Pediatr Int 2001; 43: 115-9.